TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Hangzhou Tigermed Consulting Co., Ltd. Class H ( (HK:3347) ) has issued an announcement.
Hangzhou Tigermed Consulting Co., Ltd. has established a Remuneration and Evaluation Committee to improve its corporate governance structure. This committee is responsible for formulating evaluation standards and remuneration policies for directors and senior management, ensuring accountability to the board of directors. The committee’s establishment is expected to enhance transparency and formalize procedures for remuneration policies, potentially impacting the company’s operational efficiency and stakeholder trust.
The most recent analyst rating on (HK:3347) stock is a Sell with a HK$37.00 price target. To see the full list of analyst forecasts on Hangzhou Tigermed Consulting Co., Ltd. Class H stock, see the HK:3347 Stock Forecast page.
More about Hangzhou Tigermed Consulting Co., Ltd. Class H
Hangzhou Tigermed Consulting Co., Ltd. operates in the consulting industry, focusing on providing evaluation and remuneration services for directors and senior management members. The company aims to enhance corporate governance through structured evaluation and remuneration systems.
Average Trading Volume: 4,878,203
Technical Sentiment Signal: Buy
Current Market Cap: HK$55.09B
Find detailed analytics on 3347 stock on TipRanks’ Stock Analysis page.